---
title: Clinical Data Analysis Platform
client: Contract Research Organization
vertical: Life Sciences
summary: Built a scalable data analysis platform that reduced clinical trial data lock timelines by 40% while improving data integrity and audit traceability.
---

## Background

A contract research organization (CRO) managing multiple Phase II and Phase III clinical trials was struggling with data lock timelines. The process of cleaning, transforming, and locking clinical trial data involved multiple teams, numerous manual handoffs, and a collection of ad-hoc scripts that were difficult to validate.

## Challenge

Clinical data management in a regulated environment requires:

- Complete audit trails for every data transformation
- Validated processes that produce reproducible results
- Ability to demonstrate data integrity to FDA reviewers
- Support for multiple data standards (CDASH, SDTM, ADaM)
- Integration with multiple clinical data management systems (CDMS) and electronic data capture (EDC) platforms

The existing approach — a mix of SAS scripts, Excel workbooks, and manual steps — could not provide the auditability or efficiency the organization needed as trial volumes grew.

## Solution

KSM designed and built a unified clinical data analysis platform on AWS, using Python and R for statistical processing, with a comprehensive audit framework that captured every data transformation with full provenance.

**Platform components:**

- **Ingest Layer:** Automated connectors to Medidata Rave, Oracle Clinical, and custom EDC systems
- **Data Standardization:** Automated CDASH → SDTM mapping with configurable transformation rules
- **Analysis Datasets:** ADaM dataset generation with full lineage tracking
- **Audit Engine:** Immutable event log capturing every transformation, version, and reviewer action
- **Reviewer Interface:** Web-based data review tool with side-by-side raw vs. transformed data views and discrepancy flagging
- **Submission Packages:** Automated generation of CDISC-compliant submission datasets and define.xml

## Results

- Data lock timelines reduced by 40% across all active trials
- Validation documentation effort reduced by 65% through automated evidence generation
- Zero data integrity findings in subsequent FDA and EMA review
- Platform scaled to support 23 concurrent trials within 18 months of launch
